Document:

Exhibit 10.2

 

Amendment to License
AND DEVELOPMENT agreement

 

This amendment refers to the License and Development Agreement entered
into the 1st of January, 2019 (the ”Agreement”) between the parties:

 

ColoAlert AS, Storgata 61 0504, 4307 Sandnes, Norway, company registration
number 913 028 570 ("CA"), and PharmGenomics GmbH, Robert-Koch-Straße 50, 55129 Mainz, Germany, company registration
number HRB 41529 ("PGx"), in the following referred to individually as "Party" and jointly the "Parties".

***

WHereas

 

The Agreement shall be amended to support PGx during the ongoing fundraising
process and the Covid-19 pandemic, which has caused a significant delay, possibly termination of the dIPO originally planned with the
support of Aescuvest GmbH, significantly increasing the risk of an insolvency situation.

 

Now therefore

 

in order to accommodate the needs of new situation, and to support
the commercial development of the licensed ColoAlert test, PGx and CA have agreed to enter
into this Amendment with the effective date January 1st 2020 (“Effective Date“).

 

The following clauses in the Agreement shall be replaced as of Effective
Date:

 

§6 FINANCIAL TERMS 

 

(Section “Protection fee”) The protection
fee shall be EUR five (5) per sample analysed. PGx agrees to pay outstanding Protection Fees after every ended quarter. The Protection
fee shall be calculated from Laboratory Kits sold, meaning EUR 5 multiplied with the number of analysis, which can be performed from one
Laboratory Kit sold.

 

§15 TERM AND TERMINATION

 

(section 3) CA shall have the right to terminate
this Agreement in the event that the quarterly Profit Split is less than a Minimum Profit Split. The Minimum Profit Split for the period
January 1st 2020 to December 31st 2022 shall be € 25,000, and thereafter € 250,000.

 

The Payment of the Minimum Profit Split for the 3
first quarters of 2020 is agreed to be deferred until December 31st 2021.

 

(last section) Upon termination of this Agreement
by any reason whatsoever, PGx shall immediately cease any use of the Licensed Technology, and all outstanding and or deferred payments
to CA shall immediately fall due, whether or not they are invoiced by CA.

 

		MISCELLANIOUS	

 

In case a clause in the Amendment and the Agreement
is not aligned, the Amendment shall supersede the Agreement.

 

* * *

 

This contract has been prepared in 2 originals, of which each Party
has received one.

 

Bergen/ Mainz, 25. October 2020

 

	ColoAlert AS  	 	PharmGenomics GmbH
	 	 	 
	 	 	 
	Hans Hekland  	 	Dr. Moritz EidensExhibit 10.4

 

MANAGEMENT SERVICES AGREEMENT

 

This Management Services Agreement (the “Agreement”)
is made and entered into as of July 1, 2021 by and between Guido Bächler (“Baechler”) and Mainz Biomed B.V. (the
“Company”).

 

WHEREAS, Baechler has been requested to become a director (bestuurder)
of the Company will be appointed director (bestuurder) of the Company on or around the date hereof (the “Effective Date”),

 

WHEREAS, Baechler has been granted the title of Chief Executive
Officer;

 

WHEREAS, for the purposes of Dutch law, the legal relationship
between the Company and Baechler set forth in this Agreement qualifies as a service agreement (overeenkomst van opdracht) within
the meaning of Section 7:400 et seq. of the Dutch Civil Code and the Parties do not envisage creating an employment agreement (arbeidsovereenkomst)
within the meaning of Section 7:610 et seq. of the Dutch Civil Code.

 

WHEREAS, This Agreement sets out the terms and conditions of
the services to be provided by Baechler.

 

NOW, THEREFORE, in consideration of the mutual covenants, promises,
and obligations set forth herein, the parties agree as follows:

 

1.
Term.

 

Baechler shall perform services hereunder
as of the Effective Date. The period between the Effective Date and the termination of this Agreement for any reason Baechler is hereinafter
referred to as the “Services Term”.

 

2. Position
and Duties.

 

2.1 Position. During the
Services Term, Baechler shall serve as the Chief Executive Officer at the Board of Directors of the Company (the “Board”).
In such positions, Baechler shall have such duties, authority, and responsibilities as shall be determined from time to time by the Board
and the articles of association (statuten) of the Company, which duties, authority, and responsibilities are consistent with Baechler’s
position and those assigned to Chief Executive Officers of companies listed on the Nasdaq Capital Market. The Board of Directors intends
to nominate Baechler to become and remain a member of the Company’s Board in accordance with Dutch law and the Company’s articles
of association. Baechler shall, if requested, also serve as an officer or director of any affiliate of the Company for no additional compensation.
Baechler will be given an indemnification agreement with terms reasonably satisfactory to Baechler. In addition, the Company and any such
affiliate shall at all times maintain directors and officers insurance and such other insurance as is customary for similarly situated
businesses.

 

2.2 Duties. During the Services
Term, Baechler shall devote substantially all of Baechler’s business time and attention to the performance of Baechler’s duties
hereunder; provided that you may continue as a director and/or consultant, for SummerBio, Chip Diagnostics, and Telo Genomics, and to
other entities that are not directly competitive with the Company to the extent that such activities do not conflict with your obligations
hereunder. Baechler will not otherwise engage in any other business, profession, or occupation for compensation or otherwise which would
conflict or interfere with the performance of such services either directly or indirectly without the prior written consent of the Board
(it being acknowledged by the Company, that all directorships in other entities held by Baechler on the date hereof shall not be deemed
to cause such a conflict or interference). Baechler will not be permitted without the written consent of a majority of the Board members,
which shall not be unreasonably conditioned or denied, to (a) act or serve as a director, trustee, committee member, or principal of any
type of company, entity or business, civic, or charitable organization and (b) purchase or own five percent (5%) or more of the publicly
traded securities of any corporation or have any such ownership position in such an entity that does not represent a passive investment
or that makes Baechler a controlling person of, or a member of a group that controls, such entity.

 

    1

     

    

 

3. Place
of Performance. Until such time as the Company establishes offices for its operations, Baechler shall be reimbursed up to $500 a month
for the reasonable out-of-pocket cost of maintaining his workspace or office and the costs of operating such office.

 

4. Compensation.

 

4.1 Base Remuneration. Baechler’s
annual base remuneration (the “Base Remuneration”) will initially be US$240,000 per year. The Company shall pay Baechler
an annual Base Remuneration of US$350,000 from and after the filing of a publicly available Form F-1 with respect to any initial public
offering, in the United States, of the Company’s equity securities (the “IPO”). It is anticipated that such annual
Base Remuneration shall be increased starting in the year after the IPO to US$450,000, provided that the Company has made satisfactory
progress towards Board approved strategic goals. The Company shall pay the Base Remuneration due hereunder in periodic installments, subject
to applicable withholding, and in accordance with the Company’s customary payroll practices, but no less frequently than monthly.
Baechler’s Base Remuneration shall be reviewed at least annually by the Board’s Compensation Committee or, in its absence,
the Board (the “Compensation Committee”) and the Compensation Committee may, but shall not be required to, increase
the Base Remuneration during the Services Term. However, Baechler’s base remuneration may not be decreased during the Services Term
other than as part of an across-the-board remuneration reduction that applies in the same manner and same percentage as all senior employees.
Baechler’s annual base remuneration, as in effect from time to time, is hereinafter referred to as “Base Remuneration”.

 

4.2 Annual Bonus. For each
year of the Services Term following the IPO, Baechler shall be eligible to receive an annual bonus (the “Annual Bonus”)
equal to 50% of the Base Remuneration. Baechler and the Board of Directors or Compensation Committee shall use reasonable efforts to mutually
agree upon milestones and associated and commensurate payment amounts for any such Annual Bonus thereafter. The Annual Bonus, if any,
will be paid as soon as reasonably practicable within the calendar year following the calendar year to which the Annual Bonus relates,
as determined by the Compensation Committee.

 

4.3 Equity Awards.

 

(a) In consideration
of Baechler entering into this Agreement and as an inducement to join the Company, on the Effective Date, the Company will grant 200,000
restricted ordinary shares of the Company to Baechler on the Effective Date of which 100,000 restricted ordinary shares (the “Restricted
Shares”) shall be subject to a claw-back pursuant to which the Company may repurchase all or some of such Restricted Shares at a
per share purchase price equal to 50% of the fair market value of such share when originally issued, which claw-back will lapse as to,
and no longer apply to, (i) the first 50,000 shares (x) on the one year anniversary of the IPO (or such later date agreed among Baechler
and the Company) subject to the Company and/or Baechler meeting milestones to be determined by the mutual agreement of Baechler and the
Company’s Board of Directors and/or Compensation Committee or (y) if the Company does not exercise such clawback within 30 days
of such date and (ii) an additional 50,000 shares on the (x) second anniversary of the IPO (or such later date agreed among Baechler and
the Company) subject to the Company and/or Baechler meeting milestones to be determined by the mutual agreement of Baechler and the Company’s
Board of Directors and/or Compensation Committee or (y) if the Company does not exercise such clawback within 30 days of such date. For
applicable tax reporting purposes, the Company shall treat its ordinary shares as having a fair market value of $0.30 per ordinary share,
which is the price at which the ordinary shares were most recently issued to cash investors.

 

(b) On
the date of the IPO, Baechler shall be granted options (“IPO Options”) to acquire at the exercise price per ordinary
share paid in the IPO to acquire a number of ordinary shares (currently anticipated to be 331,000 additional shares) that will equal five
percent (5%) of the outstanding ordinary shares immediately prior to the IPO (calculated excluding shares reserved for equity incentives
and outstanding warrants), less (x) the 200,000 ordinary shares issued pursuant to Section 4.3(a) and (y) 54,507 ordinary shares
previously acquired Baechler (as (x) and (y) may be adjusted for stock splits, dividends, recapitalization and the like). The IPO Options
are to be granted pursuant to a Stock Option Plan that has been approved by the Board of Directors and shareholders of the Company and
will vest over 4 years from the Effective Date in equal monthly installments, and will accelerate on a change in control or sale of substantially
all of the assets of the Company. Baechler’s equity ownership will be reviewed within 12 months of the IPO for increase, if applicable,
to be consistent with industry standards for CEOs of similarly situated companies.

 

    2

     

    

 

4.4 Health Benefit Payment.
The Company shall reimburse Baechler for payments to participate in any one U.S. health insurance plan and one U.S. dental plan (if not
included in the U.S. Health Insurance Plan) for the benefit of Baechler and any spouse or dependents eligible under such plan in an amount
of up to $3,500 per month; provided that if Baechler provides sufficient information for such payments, the Company will make such payments
directly on Baechler’s behalf when due. Such amount shall not be cumulative, and if such payments are less than $3,500 per month,
the difference shall not be available for future or prior months.

 

4.5  Benefits.
During the Services Term, Baechler shall be entitled to participate in all employee benefit plans, practices, and programs maintained
by the Company, as in effect from time to time (collectively, “Employee Benefit Plans”) to the extent consistent with
applicable law and the terms of the applicable Employee Benefit Plans. The Company reserves the right to amend or terminate any Employee
Benefit Plans at any time in its sole discretion, subject to the terms of such Employee Benefit Plan and applicable law.

 

4.6 Vacation; Paid Time-Off.
During the Services Term, Baechler shall be entitled to twenty- (20) paid vacation days per calendar year (prorated for partial years)
in accordance with the Company’s vacation policies, as in effect from time to time. Unused vacation time will rollover into future
years.

 

4.8 Business Expenses. Baechler
shall be entitled to reimbursement for all reasonable and necessary out-of-pocket business, entertainment, and travel expenses incurred
by Baechler in connection with the performance of Baechler’s duties hereunder in accordance with the Company’s expense reimbursement
policies and procedures; provided that in any calendar month where expenses are above an aggregate $10,000 any further expenses above
$2,500 individually shall be first approved by at least one independent member of the Board, unless incurred in connection with existing
Company policies.

 

4.9  Indemnification.
In the event that Baechler is made a party or threatened to be made a party to any action, suit, or proceeding, whether civil, criminal,
administrative, or investigative (a “Proceeding”), other than any Proceeding initiated by Baechler or the Company related
to any contest or dispute between Baechler and the Company or any of its affiliates with respect to this Agreement or Baechler’s
services hereunder, by reason of the fact that Baechler is or was a director or officer of the Company, or any affiliate of the Company,
or is or was serving at the request of the Company as a director, officer, member, employee, or agent of another corporation or a partnership,
joint venture, trust, or other enterprise, Baechler shall be indemnified and held harmless by the Company to the fullest extent applicable
to any other officer or director of the Company from and against any liabilities, costs, claims, and expenses, including all reasonable
costs and expenses incurred in defense of any Proceeding (including attorneys’ fees). Moreover, the Company shall advance such reasonable
costs such that Baechler will not have to submit such costs for reimbursement. This indemnification obligation shall be further documented
pursuant to an indemnification agreement with customary terms and conditions that are acceptable to Baechler and the Company.

 

    3

     

    

 

5. Termination of Agreement.
This Agreement and the Services Term may be terminated by either the Company or Baechler at any time and for any reason; provided that,
unless otherwise provided herein, either party shall be required to give the other party at least ten (10) days advance written notice
of any termination of this Agreement. Upon termination of this Agreement, Baechler shall be entitled to the compensation and benefits
described in this Section 5 and shall have no further rights to any compensation or any other benefits from the Company or any of its
affiliates.

 

This Agreement will terminate automatically upon:

 

		i.	resignation or death of Baechler; or

 

		ii.	dismissal of Baechler by the general meeting of the Company, in accordance with the articles of association
of the Company.

 

The general meeting of the Company may at any
time suspend and dismiss Baechler, with due observance of the articles of association. Suspension of Baechler will not terminate this
Agreement or the obligations of the parties hereunder. Any termination of this Agreement pursuant to (ii) (dismissal) shall be deemed
a termination by the Company for the purposes of this Agreement.

 

5.1  Termination For
Cause or Without Good Reason.

 

(a) This
Agreement may be terminated by the Company for Cause or by Baechler without Good Reason. If this Agreement is terminated by the Company
for Cause or by Baechler without Good Reason, Baechler shall be entitled to receive upon the Termination Date (as defined below):

 

(i) any
accrued but unpaid Base Remuneration and accrued but unused vacation which shall be paid;

 

(ii) reimbursement
for unreimbursed business expenses properly incurred by Baechler, which shall be subject to and paid in accordance with the Company’s
expense reimbursement policy; and

 

(iii) such benefits (including
equity compensation), if any, to which Baechler may be entitled under the Company’s employee benefit plans as of the Termination
Date; provided that, in no event shall Baechler be entitled to any payments in the nature of severance or termination payments except
as specifically provided herein.

 

Items 5.1(a)(i) through 5.1(a)(iii)
are referred to herein collectively as the “Accrued Amounts”.

 

(b) For purposes of this
Agreement, “Cause” shall mean:

 

		(i)	the willful, substantial and continuing failure of Baechler, after
specific written notice thereof, to render services to the Company in accordance with the terms or requirements of employment, which
is not cured within thirty (30) days of such notice;

 

		(ii)	Baechler’s willful failure to attempt in good faith to implement a clear, reasonable valid and legal
directive of the Board;

 

		(iii)	Baechler’s engagement in material dishonesty, illegal conduct, or other material misconduct, which
is, in each case, materially injurious to the Company or its affiliates;

 

		(iv)	Baechler’s conviction of embezzlement, material misappropriation, or willful fraud (1) related to
Baechler’s services to the Company or (2) which would material harm to the business, standing or reputation of the Company

 

    4

     

    

 

		(v)	Baechler’s conviction of or plea of guilty or nolo contendere to a crime that constitutes a felony
(or state law equivalent) or a crime that constitutes a misdemeanor involving moral turpitude;

 

		(vi)	Baechler’s deliberate disregard of the written rules or policies of the Company which is, in each
case, materially injurious to the Company or its affiliates;

 

		(vii)	Baechler’s willful unauthorized disclosure of Confidential Information (as defined below) in a manner
not reasonably believed to be in furtherance of the interests of the Company, and which is, in each case, materially injurious to the
Company or its affiliates; or

 

		(viii)	Baechler’s willful and material breach of any material obligation under this Agreement or any other
written agreement between Baechler and the Company, which breach is not cured in all material respects within 30 days of specific written
notice with respect theretofore.

 

(c) For
purposes of this Agreement, “Good Reason” shall mean the occurrence of any of the following, in each case during the
Services Term without Baechler’s written consent:

 

		(i)	a material reduction in Baechler’s Base Remuneration (other than a general reduction in Base Remuneration
that affects all similarly situated employees in substantially the same proportions);

 

		(ii)	a material reduction in Baechler’s authority, duties or
responsibilities, which shall include, without limitation, any situation other than Baechler’s resignation that results in Baechler
no longer serving on the Board of Directors;

 

		(iii)	a relocation of Baechler’s principal place of service with
the Company to a place that increases Baechler’s one-way commute by more than thirty-five (35) miles as compared to Baechler’s
then-current principal place of service immediately prior to such relocation (excluding regular travel in the ordinary course of business);
or

 

		(iv)	any material breach by the Company of any material provision of
this Agreement or any material provision of any other agreement between Baechler and the Company.

 

Except in the case of dismissal as a
director, Baechler cannot resign for Good Reason unless Baechler has provided written notice to the Company of the existence of the circumstances
providing grounds for termination for Good Reason within ninety (90) days of learning of the initial existence of such grounds and the
Company has thirty (30) days from the date on which such notice is provided to cure such circumstances. If Baechler does not resign for
Good Reason within t ninety (90) days after the first occurrence of the applicable grounds, then Baechler will be deemed to have waived
Baechler’s right to terminate for Good Reason with respect to such grounds.

 

    5

     

    

 

5.2 Termination Without Cause
or for Good Reason. This Agreement and the Services Term may be terminated by Baechler for Good Reason or by the Company without
Cause. In the event of such termination, Baechler shall be entitled to receive the Accrued Amounts and subject to Baechler’s compliance
with ii, Section 7, Section 8, and Section 9 of this Agreement and Baechler’s execution of a
release of claims in favor of the Company, its affiliates and their respective officers and directors in a form provided by the Company
(the “Release”) and such Release becoming effective within 60 days following the Termination Date (such 60-day period,
the “Release Execution Period”), Baechler shall be entitled to receive the following:

 

		(a)	equal installment payments payable in accordance with the Company’s
normal payroll practices, but no less frequently than monthly, which are in the aggregate equal to Baechler’s Base Salary for the
year in which the Termination Date occurs, which shall begin within ten (10) days following the Termination Date; provided that, the
first installment payment shall include all amounts that would otherwise have been paid to Baechler during the period beginning on the
Termination Date and ending twelve (12) months thereafter;

 

		(b)	An amount equal to Baechler’s target Annual Bonus for the
year in which the termination takes place, with all criterion for such Annual Bonus deemed to be achieved; and

 

		(c)	Vesting of an additional 12 months (removing any cliff) under
all time-based vesting schedules for equity based incentives held by Baechler;

 

(d) the Company shall reimburse Baechler for up
to $3,500 of the monthly U.S. health insurance premium paid by Baechler for himself and his dependents. Such reimbursement shall be paid
to Baechler on the tenth of the month immediately following the month in which Baechler timely remits the premium payment. Baechler shall
be eligible to receive such reimbursement until the earliest of: (i) the 12-month anniversary of the Termination Date; (ii) the date Baechler
is no longer eligible to receive COBRA continuation coverage; and (iii) the date on which Baechler becomes eligible to receive health
insurance coverage from another employer or other source. Notwithstanding the foregoing, if the Company’s making payments under this Section
5.2(d) would violate the nondiscrimination rules applicable to non-grandfathered plans under the Affordable Care Act (the “ACA”),
or result in the imposition of penalties under the ACA and the related regulations and guidance promulgated thereunder), the parties agree
to reform this Section 5.2(d) in a manner as is necessary to comply with the ACA, while providing as much of the intended benefit
as possible.]

 

5.3 Death or Disability.

 

(a) Baechler’s
employment hereunder shall terminate automatically upon Baechler’s death during the Services Term, and the Company may terminate
Baechler’s this Agreement on account of Baechler’s Disability.

 

(b) If
this Agreement on account of Baechler’s death or Disability, Baechler (or Baechler’s estate and/or beneficiaries, as the case
may be) shall be entitled to receive the Accrued Amounts. Notwithstanding any other provision contained herein, all payments made in connection
with Baechler’s Disability shall be provided in a manner which is consistent with federal and state law.

 

(c) For
purposes of this Agreement, “Disability” shall mean Baechler’s inability, due to physical or mental incapacity,
to perform the essential functions of Baechler’s job, with or without reasonable accommodation, for one hundred eighty (180) days
out of any three hundred sixty-five (365) day period or one hundred twenty (120) consecutive days. Any question as to the existence of
Baechler’s Disability as to which Baechler and the Company cannot agree shall be determined in writing by a qualified independent
physician mutually acceptable to Baechler and the Company. If Baechler and the Company cannot agree as to a qualified independent physician,
each shall appoint such a physician and those two physicians shall select a third who shall make such determination in writing. The determination
of Disability made in writing to the Company and Baechler shall be final and conclusive for purposes of this Agreement.

 

    6

     

    

 

5.4  Notice of Termination.
Any termination of this Agreement hereunder by the Company or by Baechler during the Services Term (other than termination pursuant to
Section 5.3(a) on account of Baechler’s death) shall be communicated by written notice of termination (“Notice of Termination”)
to the other party hereto in accordance with Section 27. The Notice of Termination shall specify:

 

(a) The
termination provision of this Agreement relied upon;

 

(b) To
the extent applicable, the facts and circumstances claimed to provide a basis for termination of Baechler’s services under the provision
so indicated; and

 

(c) The
applicable Termination Date.

 

5.5  Termination Date.
Baechler’s “Termination Date” shall be:

 

(a)  If this Agreement
is terminated on account of Baechler’s death, the date of Baechler’s death;

 

(b) If
this Agreement is terminated on account of Baechler’s Disability, the date that it is determined that Baechler has a Disability;

 

(c)  If the Company terminates
this Agreement hereunder for Cause, the date the Notice of Termination is delivered to Baechler;

 

(d) If
the Company terminates this Agreement without Cause, the date specified in the Notice of Termination, which shall be no less than ten
(10) days following the date on which the Notice of Termination is delivered; provided that, the Company shall have the option to provide
Baechler with a lump sum payment equal to ten (10) days’ Base Remuneration in lieu of such notice, which shall be paid in a lump
sum on Baechler’s Termination Date and for all purposes of this Agreement, Baechler’s Termination Date shall be the date on
which such Notice of Termination is delivered;

 

(e) If
Baechler terminates this Agreement with or without Good Reason, the date specified in Baechler’s Notice of Termination, which shall
be no less than ten (10) days following the date on which the Notice of Termination is delivered; provided that, the Company may waive
all or any part of the notice period for no consideration by giving written notice to Baechler and for purposes of this Agreement, Baechler’s
Termination Date shall be the date determined by the Company; and

 

Notwithstanding anything contained
herein, the Termination Date shall not occur until the date on which Baechler incurs a “separation from service” within the
meaning of Section 409A.

 

5.6  Resignation of
All Other Positions. Upon termination of this Agreement for any reason, Baechler shall be deemed to have resigned from all positions
that Baechler holds as an officer or member of the Board (or a committee thereof) of the Company or any of its affiliates (unless otherwise
agreed to by a majority of the Board).

 

5.9 Section 280G.

 

(a) If
any of the payments or benefits received or to be received by Baechler (including, without limitation, any payment or benefits received
in connection with a Change in Control or Baechler’s termination, whether pursuant to the terms of this Agreement or any other plan,
arrangement, or agreement, or otherwise) (all such payments collectively referred to herein as the “280G Payments”)
constitute “parachute payments” within the meaning of Section 280G of the Code and would, but for this Section 5.9, be subject
to the excise tax imposed under Section 4999 of the Code (the “Excise Tax”), then such 280G Payments shall be reduced
in a manner reasonably determined by the Company (by the minimum possible amounts) that is consistent with the requirements of Section
409A solely to the extent that, and only until, the amount to be received by Baechler on an after-tax basis is greater than the amount
that would be received by Baechler in the absence of any such reduction.

 

(b) All
calculations and determinations under this Section 5.9 shall be made by an independent accounting firm or independent tax counsel appointed
by the Company (the “Tax Counsel”) whose determinations shall be conclusive and binding on the Company and Baechler
for all purposes. For purposes of making the calculations and determinations required by this Section 5.9, the Tax Counsel may rely on
reasonable, good faith assumptions and approximations concerning the application of Section 280G and Section 4999 of the Code. The Company
and Baechler shall furnish the Tax Counsel with such information and documents as the Tax Counsel may reasonably request in order to make
its determinations under this Section 5.9. The Company shall bear all costs the Tax Counsel may reasonably incur in connection with its
services.

 

    7

     

    

 

6.  Cooperation. The parties
agree that certain matters in which Baechler will be involved during the Services Term may necessitate Baechler’s cooperation in
the future. Accordingly, following the termination of this Agreement for any reason, to the extent reasonably requested by the Board,
Baechler shall cooperate with the Company in connection with matters arising out of Baechler’s service to the Company; provided
that, the Company shall make reasonable efforts to minimize disruption of Baechler’s other activities. The Company shall reimburse
Baechler for reasonable expenses incurred in connection with such cooperation and, to the extent that Baechler is required to spend more
than a de minimus amount of time on such matters, the Company shall compensate Baechler at an hourly rate based on Baechler’s Base
Remuneration on the Termination Date.

 

7. Confidential Information.
Baechler understands and acknowledges that during the Services Term, Baechler will have access to and learn about Confidential Information,
as defined below.

 

7.1  Confidential
Information Defined.

 

(a) Definition.

 

For purposes of this Agreement, “Confidential
Information” includes, but is not limited to, all information not generally known to the public, in spoken, printed, electronic
or any other form or medium, including that relating directly or indirectly to: business processes, practices, methods, policies, plans,
publications, documents, research, operations, services, strategies, techniques, agreements, contracts, terms of agreements, transactions,
potential transactions, negotiations, pending negotiations, know-how, trade secrets, computer programs, computer software, applications,
operating systems, software design, web design, work-in-process, databases, manuals, records, articles, systems, material, sources of
material, supplier information, vendor information, financial information, results, accounting information, accounting records, legal
information, marketing information, advertising information, pricing information, credit information, design information, payroll information,
staffing information, personnel information, employee lists, supplier lists, vendor lists, developments, reports, internal controls, security
procedures, graphics, drawings, sketches, market studies, sales information, revenue, costs, formulae, notes, communications, algorithms,
product plans, designs, styles, models, ideas, audiovisual programs, inventions, unpublished patent applications, original works of authorship,
discoveries, experimental processes, experimental results, specifications, customer information, customer lists, client information, client
lists, manufacturing information, factory lists, distributor lists, and buyer lists of the Company Group or its businesses or any existing
or prospective customer, supplier, investor or other associated third party, or of any other person or entity that has entrusted information
to the Company Group in confidence.

 

Baechler understands that the above
list is not exhaustive, and that Confidential Information also includes other information that is marked or otherwise identified as confidential
or proprietary, or that would otherwise appear to a reasonable person to be confidential or proprietary in the context and circumstances
in which the information is known or used.

 

Baechler understands and agrees that
Confidential Information includes information developed by Baechler in the course of Baechler’s engagement by the Company as if
the Company furnished the same Confidential Information to Baechler in the first instance. Confidential Information shall not include
information that is generally available to and known by the public at the time of disclosure to Baechler; provided that, such disclosure
is through no direct or indirect fault of Baechler or person(s) acting on Baechler’s behalf.

 

    8

     

    

 

(b)  Company Creation
and Use of Confidential Information.

 

Baechler understands and acknowledges
that the Company and its affiliates (the “Group”) have invested, and continue to invest, substantial time, money, and specialized
knowledge into developing their resources, creating a customer base, generating customer and potential customer lists, training its employees,
and improving its offerings and business. Baechler understands and acknowledges that as a result of these efforts, the they have created,
and continue to use and create Confidential Information. This Confidential Information provides them with a competitive advantage over
others in the marketplace.

 

(c)  Disclosure and
Use Restrictions.

 

Baechler agrees and covenants: (i) to
treat all Confidential Information as strictly confidential; (ii) not to directly or indirectly disclose, publish, communicate, or make
available Confidential Information, or allow it to be disclosed, published, communicated, or made available, in whole or part, to any
entity or person whatsoever (including other employees of the Group) not having a need to know and authority to know and use the Confidential
Information in connection with the business of the Group and, in any event, not to anyone outside of the direct employ of the Group except
as required in the performance of Baechler’s duties to the Company or with the prior consent of the Board acting on behalf of the
Group in each instance (and then, such disclosure shall be made only within the limits and to the extent of such duties or consent); and
(iii) not to access or use any Confidential Information, and not to copy any documents, records, files, media, or other resources containing
any Confidential Information, or remove any such documents, records, files, media, or other resources from the premises or control of
the Group, except as required in the performance of Baechler’s duties to the Company or with the prior consent of the Board acting
on behalf of the Group in each instance (and then, such disclosure shall be made only within the limits and to the extent of such duties
or consent). Nothing herein shall be construed to prevent disclosure of Confidential Information as may be required by applicable law
or regulation, or pursuant to the valid order of a court of competent jurisdiction or an authorized government agency, provided that the
disclosure does not exceed the extent of disclosure required by such law, regulation, or order. Baechler shall promptly provide written
notice of any such order to the Board.

 

8. Restrictive Covenants.

 

8.1  Acknowledgement.
Baechler understands that the nature of Baechler’s position gives Baechler access to and knowledge of Confidential Information and
places Baechler in a position of trust and confidence with the Group. Baechler understands and acknowledges that the intellectual or artistic
and other services Baechler provides to the Group are unique, special, or extraordinary because of the unique nature of the automotive
and manufacturing industries.

 

Baechler further understands and acknowledges
that the Group’s ability to reserve these for the exclusive knowledge and use of the Group is of great competitive importance and
commercial value to the Group, and that improper use or disclosure by Baechler is likely to result in unfair or unlawful competitive activity.

 

 

8.2 Non-Solicitation
of Employees. Baechler agrees and covenants not to directly or indirectly solicit, , recruit, or recruit, or induce the termination
of employment of any employee of the Group during twelve (12) months, to run consecutively, beginning on Termination Date; provided however
that this Section 8.2 does not apply to any such employee that responds to a position opening that is generally advertised and not targeted
towards such individual or any employee that contacts Baechler without first being directly or indirectly contacted by Baechler.

 

8.3 Non-Solicitation
of Customers. Baechler understands and acknowledges that because of Baechler’s experience with and relationship to the Group,
Baechler will have access to and learn about much or all of the Group’s customer information. “Customer Information”
includes, but is not limited to, names, phone numbers, addresses, e-mail addresses, order history, order preferences, chain of command,
pricing information, and other information identifying facts and circumstances specific to the customer and relevant to sales and/or services.

 

    9

     

    

 

Baechler understands and acknowledges
that loss of this customer relationship and/or goodwill will cause significant and irreparable harm.

 

Baechler agrees and covenants, during
eighteen (18) months, to run consecutively, beginning on the last day of Baechler’s engagement with the Company, not to use the
Company’s trade secrets to directly or indirectly solicit, contact (including but not limited to e-mail, regular mail, express mail,
telephone, fax, and instant message), attempt to contact, or meet with the Company’s current, customers (as of the Termination Date)
for purposes of offering or accepting goods or services similar to or competitive with those offered by the Company.

 

9.  Non-Disparagement. Baechler
and Company each agree and covenants that such party will not at any time make, publish or communicate to any person or entity or in any
public forum any defamatory or disparaging remarks, comments, or statements concerning the Group or its businesses, or any of its employees,
officers, and investors and other associated third parties or Baechler.

 

This Section 9 does not, in any way, restrict
or impede Baechler from exercising protected rights to the extent that such rights cannot be waived by agreement or from complying with
any applicable law or regulation or a valid order of a court of competent jurisdiction or an authorized government agency, provided that
such compliance does not exceed that required by the law, regulation, or order. Baechler shall promptly provide written notice of any
such order to the Board.

 

10.  Acknowledgement. Baechler
acknowledges and agrees that the services to be rendered by Baechler to the Company are of a special and unique character; that Baechler
will obtain knowledge and skill relevant to the Company’s industry, methods of doing business and marketing strategies by virtue
of Baechler’s relationship with the Company; and that the restrictive covenants and other terms and conditions of this Agreement
are reasonable and reasonably necessary to protect the legitimate business interest of the Group.

 

Baechler further acknowledges that the amount
of Baechler’s compensation reflects, in part, Baechler’s obligations and the Company’s rights under Section 7, Section
8, and Section 9 of this Agreement; that Baechler has no expectation of any additional compensation, royalties or other payment of any
kind not otherwise referenced herein in connection herewith; and that Baechler will not be subject to undue hardship by reason of Baechler’s
full compliance with the terms and conditions of Section 7, Section 8, and Section 9 of this Agreement or the Company’s enforcement
thereof.

 

11.  Remedies. In the event
of a breach or threatened breach by Baechler of Section 7, Section 8, or Section 9 of this Agreement, Baechler hereby consents and agrees
that the Company shall be entitled to seek, in addition to other available remedies, a temporary or permanent injunction or other equitable
relief against such breach or threatened breach from any court of competent jurisdiction, without the necessity of showing any actual
damages or that money damages would not afford an adequate remedy, and without the necessity of posting any bond or other security. The
aforementioned equitable relief shall be in addition to, not in lieu of, legal remedies, monetary damages, or other available forms of
relief

 

12.  Arbitration. Any dispute,
controversy, or claim arising out of or related to this Agreement or any breach of this Agreement shall be submitted to and decided by
binding arbitration. Arbitration shall be administered exclusively by the American Arbitration Association under its Employment Arbitration
Rules and Mediation Procedures and judgment upon the award rendered by the arbitrator(s) may be entered in any court having jurisdiction
thereof.. Any arbitral award determination shall be final and binding upon the parties.

 

    10

     

    

 

13.  Proprietary Rights.

 

13.1  Work
Product. Baechler acknowledges and agrees that all right, title, and interest in and to all writings, works of authorship, technology,
inventions, discoveries, processes, techniques, methods, ideas, concepts, research, proposals, materials, and all other work product of
any nature whatsoever, that are created, prepared, produced, authored, edited, amended, conceived, or reduced to practice by Baechler
individually or jointly with others during the Services Term and relate in any way to the business or contemplated business, products,
activities, research, or development of the Company or result from any work performed by Baechler for the Company (in each case, regardless
of when or where prepared or whose equipment or other resources is used in preparing the same), all rights and claims related to the foregoing,
and all printed, physical and electronic copies, and other tangible embodiments thereof (collectively, “Work Product”),
as well as any and all rights in and to US and foreign (a) patents, patent disclosures and inventions (whether patentable or not), (b)
trademarks, service marks, trade dress, trade names, logos, corporate names, and domain names, and other similar designations of source
or origin, together with the goodwill symbolized by any of the foregoing, (c) copyrights and copyrightable works (including computer programs),
mask works, and rights in data and databases, (d) trade secrets, know-how, and other confidential information, and (e) all other intellectual
property rights, in each case whether registered or unregistered and including all registrations and applications for, and renewals and
extensions of, such rights, all improvements thereto and all similar or equivalent rights or forms of protection in any part of the world
(collectively, “Intellectual Property Rights”), shall be the sole and exclusive property of the Company.

 

For purposes of this Agreement, Work
Product includes, but is not limited to, Group information, including plans, publications, research, strategies, techniques, agreements,
documents, contracts, terms of agreements, negotiations, know-how, computer programs, computer applications, software design, web design,
work in process, databases, manuals, results, developments, reports, graphics, drawings, sketches, market studies, formulae, notes, communications,
algorithms, product plans, product designs, styles, models, audiovisual programs, inventions, unpublished patent applications, original
works of authorship, discoveries, experimental processes, experimental results, specifications, customer information, client information,
customer lists, client lists, manufacturing information, marketing information, advertising information, and sales information.

 

13.2  Work Made for
Hire; Assignment. Baechler acknowledges that, by reason of being employed by the Company at the relevant times, to the extent permitted
by law, all of the Work Product consisting of copyrightable subject matter is “work made for hire” as defined in 17 U.S.C.
§ 101 and such copyrights are therefore owned by the Company. To the extent that the foregoing does not apply, Baechler hereby irrevocably
assigns to the Company, for no additional consideration, Baechler’s entire right, title, and interest in and to all Work Product
and Intellectual Property Rights therein, including the right to sue, counterclaim, and recover for all past, present, and future infringement,
misappropriation, or dilution thereof, and all rights corresponding thereto throughout the world. Nothing contained in this Agreement
shall be construed to reduce or limit the Company’s rights, title, or interest in any Work Product or Intellectual Property Rights
so as to be less in any respect than that the Company would have had in the absence of this Agreement.

 

13.3  Further Assurances;
Power of Attorney. During and after the Services Term, Baechler agrees to reasonably cooperate with the Company to (a) apply for,
obtain, perfect, and transfer to the Company the Work Product as well as any and all Intellectual Property Rights in the Work Product
in any jurisdiction in the world; and (b) maintain, protect and enforce the same, including, without limitation, giving testimony and
executing and delivering to the Company any and all applications, oaths, declarations, affidavits, waivers, assignments, and other documents
and instruments as shall be requested by the Company. Baechler hereby irrevocably grants the Company power of attorney to execute and
deliver any such documents on Baechler’s behalf in Baechler’s name and to do all other lawfully permitted acts to transfer
the Work Product to the Company and further the transfer, prosecution, issuance, and maintenance of all Intellectual Property Rights therein,
to the full extent permitted by law, if Baechler in physically unable to cooperate with the Company’s request (without limiting
the rights the Company shall have in such circumstances by operation of law). The power of attorney is coupled with an interest and shall
not be affected by Baechler’s subsequent incapacity.

 

    11

     

    

 

13.4  No License.
Baechler understands that this Agreement does not, and shall not be construed to, grant Baechler any license or right of any nature with
respect to any Work Product or Intellectual Property Rights or any Confidential Information, materials, software, or other tools made
available to Baechler by the Company.

 

14. Security.

 

14.1  Security and
Access. Baechler agrees and covenants (a) to comply with all Group security policies and procedures as in force from time to time
including without limitation those regarding computer equipment, telephone systems, voicemail systems, facilities access, monitoring,
key cards, access codes, Group intranet, internet, social media and instant messaging systems, computer systems, e-mail systems, computer
networks, document storage systems, software, data security, encryption, firewalls, passwords and any and all other Group facilities,
IT resources and communication technologies (“Facilities and Information Technology Resources”); (b) not to access
or use any Facilities and Information Technology Resources except as authorized by the Company; and (iii) not to access or use any Facilities
and Information Technology Resources in any manner after the termination of Baechler’s engagement by the Company, whether termination
is voluntary or involuntary. Baechler agrees to notify the Company promptly in the event Baechler learns of any violation of the foregoing
by others, or of any other misappropriation or unauthorized access, use, reproduction, or reverse engineering of, or tampering with any
Facilities and Information Technology Resources or other Group property or materials by others.

 

14.2  Exit Obligations.
Upon (a) voluntary or involuntary termination of this Agreement or (b) the Company’s request at any time during Baechler’s
engagement, Baechler shall (i) provide or return to the Company any and all Group property, including keys, key cards, access cards, identification
cards, security devices, employer credit cards, network access devices, computers, cell phones, smartphones, PDAs, pagers, fax machines,
equipment, speakers, webcams, manuals, reports, files, books, compilations, work product, e-mail messages, recordings, tapes, disks, thumb
drives or other removable information storage devices, hard drives, negatives, and data and all Group documents and materials belonging
to the Company and stored in any fashion, including but not limited to those that constitute or contain any Confidential Information or
Work Product, that are in the possession or control of Baechler, whether they were provided to Baechler by the Group or any of its business
associates or created by Baechler in connection with Baechler’s employment by the Company; and (ii) delete or destroy all copies
of any such documents and materials not returned to the Company that remain in Baechler’s possession or control, including those
stored on any non- Group devices, networks, storage locations, and media in Baechler’s possession or control.

 

15.  Publicity. Baechler
hereby irrevocably consents to any and all good faith, reasonable uses and displays, by the Group and its agents, representatives and
licensees, of Baechler’s name, voice, likeness, image, appearance, and biographical information in, on or in connection with any
pictures, photographs, audio and video recordings, digital images, websites, television programs and advertising, other advertising and
publicity, sales and marketing brochures, books, magazines, other publications, CDs, DVDs, tapes, and all other printed and electronic
forms and media throughout the world, at any time during or after the period of Baechler’s engagement by the Company, for all legitimate
commercial and business purposes of the Group (“Permitted Uses”) without further consent from or royalty, payment,
or other compensation to Baechler. Baechler hereby forever waives and releases the Group and its directors, officers, employees, and agents
from any and all claims, actions, damages, losses, costs, expenses, and liability of any kind, arising under any legal or equitable theory
whatsoever at any time during or after the period of Baechler’s engagement by the Company, arising directly or indirectly from the
Group’s and its agents’, representatives’, and licensees’ exercise of their rights in connection with any Permitted
Uses.

 

16. Governing Law: Jurisdiction
and Venue. This Agreement, for all purposes, shall be construed in accordance with the laws of California without regard to conflicts
of law principles. To the extent that any action or proceeding by either of the parties to enforce this Agreement is not brought in accordance
the arbitration provisions of Section 12 hereof, they shall be brought exclusively in a state or federal court located in Santa Clara
County, CA. The parties hereby irrevocably submit to the exclusive jurisdiction of such courts and waive the defense of inconvenient forum
to the maintenance of any such action or proceeding in such venue. Nothing contained herein is intended to affect or modify the characterization
of Baechler’s relationship with the Company as such relationship may be provided for under California law.

 

    12

     

    

 

17.  Entire Agreement. Unless
specifically provided herein, this Agreement contains all of the understandings and representations between Baechler and the Company pertaining
to the subject matter hereof and supersedes all prior and contemporaneous understandings, agreements, representations and warranties,
both written and oral, with respect to such subject matter. The parties mutually agree that the Agreement can be specifically enforced
in court and can be cited as evidence in legal proceedings alleging breach of the Agreement.

 

19.  Modification and Waiver.
No provision of this Agreement may be amended or modified unless such amendment or modification is agreed to in writing and signed by
Baechler and by the Chairman of the Company’s Board of Directors as directed by the Board and/or the Compensation Committee. No
waiver by either of the parties of any breach by the other party hereto of any condition or provision of this Agreement to be performed
by the other party hereto shall be deemed a waiver of any similar or dissimilar provision or condition at the same or any prior or subsequent
time, nor shall the failure of or delay by either of the parties in exercising any right, power, or privilege hereunder operate as a waiver
thereof to preclude any other or further exercise thereof or the exercise of any other such right, power, or privilege.

 

20.  Severability. Should
any provision of this Agreement be held by a court of competent jurisdiction (or pursuant to arbitration under Section 12) to be enforceable
only if modified, or if any portion of this Agreement shall be held as unenforceable and thus stricken, such holding shall not affect
the validity of the remainder of this Agreement, the balance of which shall continue to be binding upon the parties with any such modification
to become a part hereof and treated as though originally set forth in this Agreement.

 

The parties further agree that any such court
is expressly authorized to modify any such unenforceable provision of this Agreement in lieu of severing such unenforceable provision
from this Agreement in its entirety, whether by rewriting the offending provision, deleting any or all of the offending provision, adding
additional language to this Agreement, or by making such other modifications as it deems warranted to carry out the intent and agreement
of the parties as embodied herein to the maximum extent permitted by law.

 

The parties expressly agree that this Agreement
as so modified shall be binding upon and enforceable against each of them. In any event, should one or more of the provisions of this
Agreement be held to be invalid, illegal, or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not
affect any other provisions hereof, and if such provision or provisions are not modified as provided above, this Agreement shall be construed
as if such invalid, illegal, or unenforceable provisions had not been set forth herein.

 

21.  Captions. Captions and
headings of the sections and paragraphs of this Agreement are intended solely for convenience and no provision of this Agreement is to
be construed by reference to the caption or heading of any section or paragraph.

 

22.  Counterparts. This Agreement
may be executed in separate counterparts, each of which shall be deemed an original, but all of which taken together shall constitute
one and the same instrument.

 

23.  Tolling. Should Baechler
violate any of the terms of the restrictive covenant obligations articulated herein, the obligation at issue will run from the first date
on which Baechler ceases to be in violation of such obligation.

 

    13

     

    

 

24. Section 409A.

 

24.1  General Compliance.
This Agreement is intended to comply with Section 409A or an exemption thereunder and shall be construed and administered in accordance
with Section 409A. Notwithstanding any other provision of this Agreement, payments provided under this Agreement may only be made upon
an event and in a manner that complies with Section 409A or an applicable exemption. Any payments under this Agreement that may be excluded
from Section 409A either as separation pay due to an involuntary separation from service or as a short-term deferral shall be excluded
from Section 409A to the maximum extent possible. For purposes of Section 409A, each installment payment provided under this Agreement
shall be treated as a separate payment. Any payments to be made under this Agreement upon a termination of this Agreement shall only be
made upon a “separation from service” under Section 409A. Notwithstanding the foregoing, the Company makes no representations
that the payments and benefits provided under this Agreement comply with Section 409A, and in no event shall the Company be liable for
all or any portion of any taxes, penalties, interest, or other expenses that may be incurred by Baechler on account of non-compliance
with Section 409A.

 

24.2  Specified Employees.
Notwithstanding any other provision of this Agreement, if any payment or benefit provided to Baechler in connection with termination of
this Agreement is determined to constitute “nonqualified deferred compensation” within the meaning of Section 409A and Baechler
is determined to be a “specified employee” as defined in Section 409A(a)(2)(b)(i), then such payment or benefit shall not
be paid until the first payroll date to occur following the six-month anniversary of the Termination Date or, if earlier, on Baechler’s
death (the “Specified Payment Date”). The aggregate of any payments that would otherwise have been paid before the
Specified Payment Date and interest on such amounts calculated based on the applicable federal rate published by the Internal Revenue
Service for the month in which Baechler’s separation from service occurs shall be paid to Baechler in a lump sum on the Specified
Payment Date and thereafter, any remaining payments shall be paid without delay in accordance with their original schedule. Each payment
hereunder shall be treated as a separate payment for purposes of applying Section 409A.

 

24.3  Reimbursements. To
the extent required by Section 409A, each reimbursement or in-kind benefit provided under this Agreement shall be provided in accordance
with the following:

 

(a) the amount of expenses
eligible for reimbursement, or in-kind benefits provided, during each calendar year cannot affect the expenses eligible for reimbursement,
or in-kind benefits to be provided, in any other calendar year;

 

(b) any reimbursement of
an eligible expense shall be paid to Baechler on or before the last day of the calendar year following the calendar year in which the
expense was incurred; and

 

(c) any right to reimbursements
or in-kind benefits under this Agreement shall not be subject to liquidation or exchange for another benefit.

 

24.4  Tax Gross-ups. Any
tax gross-up payments provided under this Agreement shall be paid to Baechler on or before December 31 of the calendar year immediately
following the calendar year in which Baechler remits the related taxes.

 

24.5  Payments During Release
Execution Period. In that the Release Execution Period begins in one calendar year and ends in a subsequent calendar year, any payments
that would become payable to Baechler during the Release Execution Period shall be paid on the first regularly scheduled payroll date
in such subsequent calendar year.

 

25.  Notification to Subsequent
Employer. When this Agreement terminates the Company terminates, Baechler agrees to notify any subsequent employer of the restrictive
covenants sections contained in this Agreement. Baechler will also deliver a copy of such notice to the Company before Baechler commences
employment with any subsequent employer. In addition, Baechler authorizes the Company to provide a copy of the restrictive covenants sections
of this Agreement to third parties, including but not limited to, Baechler’s subsequent, anticipated, or possible future employer.

 

26.  Successors and Assigns.
This Agreement is personal to Baechler and shall not be assigned by Baechler. Any purported assignment by Baechler shall be null and void
from the initial date of the purported assignment. The Company may assign this Agreement to any successor or assign (whether direct or
indirect, by purchase, merger, consolidation, or otherwise) to all or substantially all of the business or assets of the Company. This
Agreement shall inure to the benefit of the Company and permitted successors and assigns.

 

    14

     

    

 

27.  Notice. Notices and
all other communications provided for in this Agreement shall be in writing and shall be delivered personally or sent by registered or
certified mail, return receipt requested, or by overnight carrier to the parties at the addresses set forth below (or such other addresses
as specified by the parties by like notice):

 

If to the Company:

 

Robert-Koch-Strasse 50

55129 Mainz, Germany

Attention: Marco Messina

E-Mail: marco@messina.consulting

 

If to Baechler:

 

Guido Baechler

3150 Porter Drive

Palo Alto CA 94306

Guido.baechler@mainz-biomed.com

 

With a copy (which
shall not constitute notice) to:

Adrian M. Rich

Perkins Coie LLP

arich@perkinscoie.com

 

28.  Representations of Baechler.
Baechler represents and warrants to the Company that:

 

Baechler’s execution of this Agreement and
the performance of Baechler’s duties hereunder will not conflict with or result in a violation of, a breach of, or a default under
any contract, agreement, or understanding to which Baechler is a party or is otherwise bound. Baechler’s execution of this Agreement
with the Company and the performance of Baechler’s duties hereunder will not violate any non-solicitation, non-competition, or other
similar covenant or agreement of a prior employer.

 

29.  Withholding. The Company
shall have the right to withhold from any amount payable hereunder any Federal, state, and local taxes in order for the Company to satisfy
any withholding tax obligation it may have under any applicable law or regulation.

 

30. Survival. Upon the expiration
or other termination of this Agreement, the respective rights and obligations of the parties hereto shall survive such expiration or other
termination to the extent necessary to carry out the intentions of the parties under this Agreement.

 

31. Acknowledgement of Full Understanding.
Baechler ACKNOWLEDGES AND AGREES THAT Baechler HAS FULLY READ, UNDERSTANDS AND VOLUNTARILY ENTERS
INTO THIS AGREEMENT. Baechler ACKNOWLEDGES AND AGREES THAT Baechler HAS HAD AN OPPORTUNITY TO ASK QUESTIONS AND CONSULT WITH AN ATTORNEY
OF Baechler’S CHOICE BEFORE SIGNING THIS AGREEMENT.

 

32. Expenses. Company will reimburse Baechler
for legal fees in the amount of up to $7,500 incurred in connection with the review and negotiation of this Agreement. Should Baechler
determine in the future that any request by the Company makes it desirable for Baechler to obtain individual counsel, Company shall reimburse
the reasonable fees and expenses incurred by Baechler for any such advice.

 

[Signature Page Follows]

 

    15

     

    

 

IN WITNESS WHEREOF, the parties hereto have executed
this Agreement as of the date first above written.

 

	
     

    
	Mainz Biomed B.V.

	 	 	 
	 	By	 
	 	Name:	 
	 	Title:	 

 

	BAECHLER

	 
	 	 	 
	Signature:	 	 
	Print Name:	Guido Bächler	 

 

 

16

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}]]